Cannabidiol and Management of Endometriosis Pain
A Randomized Controlled Pilot Study of the Use of Cannabidiol in the Management of Endometriosis Pain
Sponsor: Milton S. Hershey Medical Center
Terminated
Recruitment has been challenging due to the BMI cutoff, need to take oral progesterone and abstain from cannabis products prior to the study.
Other terminated trials from Milton S. Hershey Medical Center
This PHASE3 trial investigates CBD and Endometriosis and is currently terminated or withdrawn. Milton S. Hershey Medical Center leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
May 2025 — Present [monthly]
Terminated PHASE3
-
Feb 2025 — May 2025 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Sep 2024 — Feb 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Nov 2023 — Jul 2024 [monthly]
Recruiting PHASE3
▶ Show 5 earlier versions
-
Feb 2023 — Nov 2023 [monthly]
Recruiting PHASE3
Status: Active Not Recruiting → Recruiting
-
Jan 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Oct 2021 — Jan 2022 [monthly]
Recruiting PHASE3
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Milton S. Hershey Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .